AMYPAD at AD/PD 2023

The forthcoming AD/PD™ meeting will take place as a hybrid conference in Gothenburg (Sweden) and online from 28 March to 1 April 2023. The AD/PD™ Conference offers a high-quality scientific program covering the most recent research, clinical trials, developments, and treatments in Alzheimer’s and Parkinson’s disease.

The AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ is now an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

Several AMYPAD researchers will be presenting their respective work at the upcoming AD/PD™ Conference:

  • Lyduine Collij (VUmc) “Head-To-Head Comparison Between Baseline Semi- And Fully-Quantitative Amyloid-Pet Measures To Predict Changes In Cognition: The AMYPAD PNHS Study”
    Oral Presentation
    Saturday 1st April 2023, 12:40 – 12:55, Symposium PET 02, Hall G3
  • Sophie E. Mastenbroek (VUmc) “Relationship Between A Continuous Amyloid CSF/PET Discordance Measure With Demographics And Longitudinal Cognition”
    Oral Presentation
    Saturday 1st April 2023, 14:45 – 15:00, Symposium: fluid biomarkers and imaging in AD, PD AND PSP, Hall G3
  • Luigi Lorenzini (VUmc) “Cortical Amyloid Predicts Longitudinal Atrophy In Non Demented Individuals: Results From The AMYPAD Prognostic Study”
    Oral Presentation
    Saturday 1st April 2023, 18:55 – 19:10, Symposium: AD, PD, LBD, Biomarkers, Diagnosis, Imaging & Clinical Trials, Hall G4

  • Ariane Bollack (UCL) “A Centiloid window to help predict true amyloid accumulation”
    Poster Presentation

We are very much looking forward to the conference and discussing our work and results!

For more information about the event, please visit: https://adpd.kenes.com/

AMYPAD at AD/PD 2023
More News